ATE312608T1 - Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom - Google Patents
Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndromInfo
- Publication number
- ATE312608T1 ATE312608T1 AT01926590T AT01926590T ATE312608T1 AT E312608 T1 ATE312608 T1 AT E312608T1 AT 01926590 T AT01926590 T AT 01926590T AT 01926590 T AT01926590 T AT 01926590T AT E312608 T1 ATE312608 T1 AT E312608T1
- Authority
- AT
- Austria
- Prior art keywords
- cabergoline
- fibromyalgia
- treatment
- chronic fatigue
- fatigue syndrome
- Prior art date
Links
- KORNTPPJEAJQIU-KJXAQDMKSA-N Cabaser Chemical compound C1=CC([C@H]2C[C@H](CN(CC=C)[C@@H]2C2)C(=O)N(CCCN(C)C)C(=O)NCC)=C3C2=CNC3=C1 KORNTPPJEAJQIU-KJXAQDMKSA-N 0.000 title 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 title 1
- 208000001640 Fibromyalgia Diseases 0.000 title 1
- 229960004596 cabergoline Drugs 0.000 title 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19895900P | 2000-04-21 | 2000-04-21 | |
| US20056900P | 2000-04-28 | 2000-04-28 | |
| PCT/US2001/010807 WO2001081343A2 (en) | 2000-04-21 | 2001-04-17 | Compounds for treating fibromyalgia and chronic fatigue syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312608T1 true ATE312608T1 (de) | 2005-12-15 |
Family
ID=26894316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01926590T ATE312608T1 (de) | 2000-04-21 | 2001-04-17 | Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US6448258B2 (de) |
| EP (1) | EP1274430B1 (de) |
| JP (1) | JP2004502650A (de) |
| KR (1) | KR20040007215A (de) |
| CN (3) | CN1450898A (de) |
| AR (3) | AR028355A1 (de) |
| AT (1) | ATE312608T1 (de) |
| AU (2) | AU2001253114B2 (de) |
| BR (1) | BR0110210A (de) |
| CA (1) | CA2405565A1 (de) |
| DE (1) | DE60115872T2 (de) |
| DK (1) | DK1274430T3 (de) |
| ES (1) | ES2253370T3 (de) |
| NZ (3) | NZ531172A (de) |
| PE (1) | PE20011212A1 (de) |
| WO (1) | WO2001081343A2 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| BR0110188A (pt) * | 2000-04-21 | 2003-03-05 | Upjohn Co | Compostos selecionados para o tratamento de sìndromes de fibromialgia e de fadiga crÈnica |
| AR033520A1 (es) * | 2000-04-27 | 2003-12-26 | Upjohn Co | (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona |
| AU2001283393B2 (en) * | 2000-08-16 | 2005-09-22 | Pharmacia & Upjohn Company | Compounds for the treatment of addictive disorders |
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| AR031152A1 (es) * | 2000-10-31 | 2003-09-10 | Upjohn Co | Tratamientos nuevos para el sindrome de piernas inquietas |
| WO2004032853A2 (en) * | 2002-10-04 | 2004-04-22 | Pharmacia Corporation | Compositions and methods for treating sexual dysfunction |
| US20040138200A1 (en) * | 2002-10-04 | 2004-07-15 | Michael Hawley | Pharmaceutical compositions for treatment of Parkinson's disease |
| CN101263136A (zh) | 2005-07-13 | 2008-09-10 | 弗·哈夫曼-拉罗切有限公司 | 作为5-ht6、5-ht24的苯并咪唑衍生物 |
| TWI392670B (zh) * | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途 |
| ES2332645B1 (es) * | 2009-06-30 | 2010-10-18 | Grifols, S.A. | Utilizacion de alfa-1-antitripsina para la preparacion de medicamentos para el tratamiento del sindrome de fatiga cronica. |
| WO2012039660A1 (en) * | 2010-09-20 | 2012-03-29 | A. Carlsson Research Ab | Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders |
| EA035469B1 (ru) | 2013-03-15 | 2020-06-22 | Инсайт Холдингс Корпорейшн | Трициклические гетероциклы как ингибиторы белков бэт |
| EP3019502B1 (de) | 2013-07-08 | 2017-05-17 | Incyte Holdings Corporation | Tricyclische heterocyclen als bet-proteininhibitoren |
| US9399640B2 (en) | 2013-11-26 | 2016-07-26 | Incyte Corporation | Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors |
| US9315501B2 (en) | 2013-11-26 | 2016-04-19 | Incyte Corporation | Bicyclic heterocycles as BET protein inhibitors |
| US9309246B2 (en) | 2013-12-19 | 2016-04-12 | Incyte Corporation | Tricyclic heterocycles as BET protein inhibitors |
| SMT202000133T1 (it) | 2014-04-23 | 2020-05-08 | Incyte Corp | 1h-pirrolo[2,3-c]piridin-7(6h)-oni e pirazolo[3,4-c]piridin-7(6h)-oni come inibitori di proteine bet |
| DE102014008742A1 (de) * | 2014-06-12 | 2015-12-17 | Daimler Ag | Separator für einen elektrochemischen Speicher, Verfahren zur Herstellung eines Elektrodenmaterials sowie elektrochemischer Energiespeicher |
| JP6599979B2 (ja) | 2014-09-15 | 2019-10-30 | インサイト・コーポレイション | Ｂｅｔタンパク質阻害剤として用いるための三環式複素環化合物 |
| CA2982898C (en) | 2015-05-13 | 2023-08-29 | A. Carlsson Research Ab | Combination of dopamine stabilizing agent and an anti-depressive agent to treat a disorder characterized by debilitating fatigue |
| WO2017075377A1 (en) | 2015-10-29 | 2017-05-04 | Incyte Corporation | Amorphous solid form of a bet protein inhibitor |
| CN109715625B (zh) | 2016-06-20 | 2022-04-19 | 因赛特公司 | Bet抑制剂的结晶固体形式 |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526892A (en) | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
| EP0480939B1 (de) | 1989-06-09 | 1995-01-25 | The Upjohn Company | Heterozyklische amine mit zns-wirksamkeit |
| US5273975A (en) | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
| DK0641320T3 (da) | 1991-04-17 | 2001-08-20 | Upjohn Co | Substituerede (S)-3-phenylpiperidinderivater, deres fremstilling og deres anvendelse som dopaminautoreceptorantagonister |
| DE69406678T2 (de) * | 1993-07-27 | 1998-03-26 | Pharmacia & Upjohn Co., Kalamazoo, Mich. | Heterozyclische amine mit zns-wirksamkeit |
| JPH1053525A (ja) * | 1996-06-06 | 1998-02-24 | Bitakain Seiyaku Kk | 疼痛治療剤 |
| US6455564B1 (en) | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
| AU3490300A (en) * | 1999-03-12 | 2000-10-04 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
| ATE305788T1 (de) | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | (s,s)-reboxetin zur behandlung von inkontinenz |
| DE19938823A1 (de) | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
| WO2001015677A2 (en) * | 1999-08-31 | 2001-03-08 | Alcon Laboratories, Inc. | Use of 5-ht1b/1d agonists to treat otic pain |
-
2001
- 2001-04-17 CA CA002405565A patent/CA2405565A1/en not_active Abandoned
- 2001-04-17 NZ NZ531172A patent/NZ531172A/en unknown
- 2001-04-17 WO PCT/US2001/010807 patent/WO2001081343A2/en not_active Ceased
- 2001-04-17 AT AT01926590T patent/ATE312608T1/de not_active IP Right Cessation
- 2001-04-17 KR KR1020027014072A patent/KR20040007215A/ko not_active Withdrawn
- 2001-04-17 BR BR0110210-9A patent/BR0110210A/pt not_active IP Right Cessation
- 2001-04-17 CN CN01806849A patent/CN1450898A/zh active Pending
- 2001-04-17 DE DE60115872T patent/DE60115872T2/de not_active Expired - Fee Related
- 2001-04-17 DK DK01926590T patent/DK1274430T3/da active
- 2001-04-17 EP EP01926590A patent/EP1274430B1/de not_active Expired - Lifetime
- 2001-04-17 NZ NZ522112A patent/NZ522112A/en unknown
- 2001-04-17 US US09/836,660 patent/US6448258B2/en not_active Expired - Fee Related
- 2001-04-17 AU AU2001253114A patent/AU2001253114B2/en not_active Ceased
- 2001-04-17 ES ES01926590T patent/ES2253370T3/es not_active Expired - Lifetime
- 2001-04-17 CN CNA2004100476387A patent/CN1554343A/zh active Pending
- 2001-04-17 JP JP2001578433A patent/JP2004502650A/ja active Pending
- 2001-04-17 NZ NZ531171A patent/NZ531171A/en unknown
- 2001-04-17 CN CNA2004100476391A patent/CN1554341A/zh active Pending
- 2001-04-17 AU AU5311401A patent/AU5311401A/xx active Pending
- 2001-04-19 PE PE2001000357A patent/PE20011212A1/es not_active Application Discontinuation
- 2001-04-20 AR ARP010101861A patent/AR028355A1/es unknown
-
2002
- 2002-05-30 US US10/159,913 patent/US6555548B2/en not_active Expired - Fee Related
-
2003
- 2003-03-07 US US10/383,467 patent/US20030191149A1/en not_active Abandoned
- 2003-04-10 AR ARP030101259A patent/AR039633A2/es unknown
- 2003-04-10 AR ARP030101258A patent/AR039632A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2253370T3 (es) | 2006-06-01 |
| US20020143010A1 (en) | 2002-10-03 |
| JP2004502650A (ja) | 2004-01-29 |
| EP1274430A2 (de) | 2003-01-15 |
| NZ531172A (en) | 2005-07-29 |
| PE20011212A1 (es) | 2001-11-21 |
| CN1554341A (zh) | 2004-12-15 |
| NZ531171A (en) | 2005-03-24 |
| US6448258B2 (en) | 2002-09-10 |
| DK1274430T3 (da) | 2006-02-13 |
| EP1274430B1 (de) | 2005-12-14 |
| BR0110210A (pt) | 2003-01-28 |
| US6555548B2 (en) | 2003-04-29 |
| AR028355A1 (es) | 2003-05-07 |
| US20030191149A1 (en) | 2003-10-09 |
| CN1554343A (zh) | 2004-12-15 |
| NZ522112A (en) | 2004-10-29 |
| US20020004510A1 (en) | 2002-01-10 |
| WO2001081343A3 (en) | 2002-02-28 |
| CA2405565A1 (en) | 2001-11-01 |
| DE60115872D1 (de) | 2006-01-19 |
| AR039633A2 (es) | 2005-03-02 |
| WO2001081343A2 (en) | 2001-11-01 |
| CN1450898A (zh) | 2003-10-22 |
| DE60115872T2 (de) | 2006-07-13 |
| AR039632A2 (es) | 2005-03-02 |
| AU2001253114B2 (en) | 2005-08-25 |
| KR20040007215A (ko) | 2004-01-24 |
| AU5311401A (en) | 2001-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60115872D1 (de) | Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom | |
| DE60035232D1 (de) | (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom | |
| DE60035378D1 (de) | Gerät zur Behandlung von Bandscheiben | |
| DE69927971D1 (de) | Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c | |
| EP1005345A4 (de) | Methode und zusammensetzungen zur behandlung von allergischem asthma und anderen beschwerden mittels descarboethoxyloratadin | |
| EP1274444A4 (de) | Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen | |
| ATE286028T1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
| ATE291438T1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
| DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
| DE60221798D1 (de) | Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen | |
| ATE350364T1 (de) | Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen | |
| DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
| DE60138129D1 (de) | Apparat zur behandlung von zähnen | |
| DE60224163D1 (de) | Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen | |
| ATE504209T1 (de) | Methode und vorrichtung zur zufuhr von nahrungsmitteln | |
| ATE247117T1 (de) | Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen | |
| DE69817015D1 (de) | Gerät und methode zur wirkungsbegrenzung von detonationen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60134009D1 (de) | Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE60224650D1 (de) | Vorrichtung zur behandlung von vorhof-fibrillation | |
| NO20015772L (no) | Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom | |
| FI20011298L (fi) | Puunkäsittelyliuos ja menetelmä puun säilyvyyden parantamiseksi | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1274430 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |